Key result
Obesity in COVID-19 ARDS is linked to AKI requiring RRT but not higher mortality.
Why the study?
Chronic conditions like obesity are linked to adverse outcomes in COVID-19 ARDS, but the relationship between BMI and outcomes in critically ill patients required evaluation.
Does obesity increase mortality and complications in critically ill patients with COVID-19 ARDS?
Cohort (n=108)
Does obesity increase mortality and complications in critically ill patients with COVID-19 ARDS?
In patients with COVID-19 ARDS, obesity is associated with a higher risk of AKI requiring RRT but not significantly higher overall mortality, though concurrent ischemic heart disease increases mortality risk.
Answers are grounded in this paper and cite their sources.
Obesity signals higher continuous RRT need in COVID-19 ARDS; leaves open independent mortality effect and requires prospective confirmation.
Background: Chronic conditions such as obesity are associated with adverse outcomes in coronavirus disease 2019 (COVID-19) acute respiratory distress syndrome (ARDS) patients. The aim of our study was to evaluate the relationship between BMI and outcomes in critically ill patients with COVID-19 ARDS. Methods: A retrospective study including all patients with COVID-19 and ARDS on mechanical ventilation admitted to the intensive care unit (ICU) over 2 years. Patients with obesity (BMI ≥30 kg/m 2 ) were compared with those without obesity (BMI >18.5 up to 29.9 kg/m 2 ). Outcomes compared were primary (mortality, duration of mechanical ventilation, and length of ICU stay) and secondary complications during the ICU course (inotrope requirement, acute kidney injury [AKI] requiring renal replacement therapy [RRT], and bloodstream and urinary tract infections). Results: One hundred and eight patients were included in the study. The mean age of patients was 52 years, and 94 (87%) patients were males. As compared to COVID-19 ARDS patients without obesity, COVID-19 patients with obesity were more prone to develop complications like AKI, necessitating continuous RRT ( P = 0.005). There was no significant difference in other complications between the two groups (all P > 0.05). There was no increased mortality in these obese patients ( P = 0.056). In these patients with obesity, those who also had ischemic heart disease had an increased likelihood of mortality ( P = 0.036). Conclusion: Our study concludes that patients with COVID-19 ARDS who are obese are not at higher risk of mortality and more likely to develop renal complications. When these patients develop cardiac complications or bloodstream infections, they have a significantly higher risk of mortality.
No takes yet. Share an insight, caveat, or question.
Telang et al. (2024) conducted a cohort in COVID-19 acute respiratory distress syndrome (ARDS) (n=108). Obesity (BMI ≥30 kg/m2) vs. Without obesity (BMI >18.5 up to 29.9 kg/m2) was evaluated on Mortality, duration of mechanical ventilation, and length of ICU stay (p=0.056). In critically ill patients with COVID-19 ARDS, obesity was not associated with increased mortality but was linked to a higher risk of acute kidney injury requiring renal replacement therapy.
Synapse has enriched 10 related papers. Consider them for comparative context: